Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA) ; volume:10 ; number:1 ; day:29 ; month:11 ; year:2010 ; pages:1-10 ; date:12.2010
BMC public health ; 10, Heft 1 (29.11.2010), 1-10, 12.2010
- Creator
-
Pettersson, Billie
- Contributor
-
Ambegaonkar, Baishali
Sazonov, Vasilisa
Martinell, Mats
Stålhammar, Jan
Wändell, Per
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-10-737
- URN
-
urn:nbn:de:1111-2016081336134
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pettersson, Billie
- Ambegaonkar, Baishali
- Sazonov, Vasilisa
- Martinell, Mats
- Stålhammar, Jan
- Wändell, Per
- SpringerLink (Online service)
Other Objects (12)
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Glucose and Lipid Metabolism Abnormalities among Patients with Autosomal Dominant Polycystic Kidney Disease
Evolving targets for lipid‐modifying therapy
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Management of Lipid Abnormalities in Patients with Diabetes
Lipid profile and dyslipidemia among school-age children in urban Ghana
Deficiency of the lipid flippase ATP10A causes diet-induced dyslipidemia in female mice
Modeling the risk factors for dyslipidemia and blood lipid indices: Ravansar cohort study
Lipid and polymer lipid systems
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
Lipid protein interactions in lipid membranes
Lipid pigments
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease